These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 12008051)

  • 1. Design, synthesis, DNA-binding and cytotoxicity evaluation of new potential combilexines.
    Hotzel C; Marotto A; Pindur U
    Eur J Med Chem; 2002 May; 37(5):367-78. PubMed ID: 12008051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New propylamine oligopyrrole carboxamides linked to a heterocyclic or anthraquinone system: synthesis, DNA binding, topoisomerase I inhibition and cytotoxicity.
    Hotzel C; Marotto A; Pindur U
    Eur J Med Chem; 2003 Feb; 38(2):189-97. PubMed ID: 12620663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 1-[(omega-aminoalkyl)amino]-4-[N-(omega-aminoalkyl)carbamoyl]-9-oxo-9, 10-dihydroacridines as intercalating cytotoxic agents: synthesis, DNA binding, and biological evaluation.
    Antonini I; Polucci P; Jenkins TC; Kelland LR; Menta E; Pescalli N; Stefanska B; Mazerski J; Martelli S
    J Med Chem; 1997 Nov; 40(23):3749-55. PubMed ID: 9371240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, synthesis, DNA binding, and biological activity of a series of DNA minor-groove-binding intercalating drugs.
    Bailly C; Pommery N; Houssin R; Henichart JP
    J Pharm Sci; 1989 Nov; 78(11):910-7. PubMed ID: 2621573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and biological evaluation of pyrazole linked benzothiazole-β-naphthol derivatives as topoisomerase I inhibitors with DNA binding ability.
    Nagaraju B; Kovvuri J; Kumar CG; Routhu SR; Shareef MA; Kadagathur M; Adiyala PR; Alavala S; Nagesh N; Kamal A
    Bioorg Med Chem; 2019 Mar; 27(5):708-720. PubMed ID: 30679134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oligopyrrole carboxamides linked with a nucleobase as potential DNA minor groove binding ligands: synthesis, DNA binding and biological evaluation.
    Keuser C; Pindur U
    Pharmazie; 2006 Apr; 61(4):261-8. PubMed ID: 16649534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Substitution at the F-ring N-imide of the indolocarbazole antitumor drug NB-506 increases the cytotoxicity, DNA binding, and topoisomerase I inhibition activities.
    Bailly C; Qu X; Chaires JB; Colson P; Houssier C; Ohkubo M; Nishimura S; Yoshinari T
    J Med Chem; 1999 Jul; 42(15):2927-35. PubMed ID: 10425102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and antitumour activity of new dendritic polyamines-(imide-DNA-intercalator) conjugates: potent Lck inhibitors.
    Braña MF; Domínguez G; Sáez B; Romerdahl C; Robinson S; Barlozzari T
    Eur J Med Chem; 2002 Jul; 37(7):541-51. PubMed ID: 12126773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, synthesis and biological evaluation of a novel series of anthrapyrazoles linked with netropsin-like oligopyrrole carboxamides as anticancer agents.
    Zhang R; Wu X; Guziec LJ; Guziec FS; Chee GL; Yalowich JC; Hasinoff BB
    Bioorg Med Chem; 2010 Jun; 18(11):3974-84. PubMed ID: 20471276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis and biological evaluation of new oligopyrrole carboxamides linked with tricyclic DNA-intercalators as potential DNA ligands or topoisomerase inhibitors.
    David-Cordonnier MH; Hildebrand MP; Baldeyrou B; Lansiaux A; Keuser C; Benzschawel K; Lemster T; Pindur U
    Eur J Med Chem; 2007 Jun; 42(6):752-71. PubMed ID: 17433851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel pyrazolo[3,4-d]pyrimidine with 4-(1H-benzimidazol-2-yl)-phenylamine as broad spectrum anticancer agents: Synthesis, cell based assay, topoisomerase inhibition, DNA intercalation and bovine serum albumin studies.
    Singla P; Luxami V; Singh R; Tandon V; Paul K
    Eur J Med Chem; 2017 Jan; 126():24-35. PubMed ID: 27744184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential antitumor agents. 53. Synthesis, DNA binding properties, and biological activity of perimidines designed as "minimal" DNA-intercalating agents.
    Herbert JM; Woodgate PD; Denny WA
    J Med Chem; 1987 Nov; 30(11):2081-6. PubMed ID: 3669016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rebeccamycin analogues from indolo[2,3-c]carbazole.
    Voldoire A; Sancelme M; Prudhomme M; Colson P; Houssier C; Bailly C; Léonce S; Lambel S
    Bioorg Med Chem; 2001 Feb; 9(2):357-65. PubMed ID: 11249128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, synthesis, and biological properties of new bis(acridine-4-carboxamides) as anticancer agents.
    Antonini I; Polucci P; Magnano A; Gatto B; Palumbo M; Menta E; Pescalli N; Martelli S
    J Med Chem; 2003 Jul; 46(14):3109-15. PubMed ID: 12825949
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The structure-based design, synthesis, and biological evaluation of DNA-binding amide linked bisintercalating bisanthrapyrazole anticancer compounds.
    Hasinoff BB; Zhang R; Wu X; Guziec LJ; Guziec FS; Marshall K; Yalowich JC
    Bioorg Med Chem; 2009 Jul; 17(13):4575-82. PubMed ID: 19457675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antitumor agents. 3. Design, synthesis, and biological evaluation of new pyridoisoquinolindione and dihydrothienoquinolindione derivatives with potent cytotoxic activity.
    Bolognese A; Correale G; Manfra M; Lavecchia A; Mazzoni O; Novellino E; La Colla P; Sanna G; Loddo R
    J Med Chem; 2004 Feb; 47(4):849-58. PubMed ID: 14761187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential antitumor agents. 59. Structure-activity relationships for 2-phenylbenzimidazole-4-carboxamides, a new class of "minimal" DNA-intercalating agents which may not act via topoisomerase II.
    Denny WA; Rewcastle GW; Baguley BC
    J Med Chem; 1990 Feb; 33(2):814-9. PubMed ID: 2153829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functionalized and [a]-anellated carbazoles as potential B-DNA ligands: experimental studies of DNA binding and molecular modeling of intercalation complexes.
    Pindur U; Marotto A; Schulze E; Fischer G
    Pharmazie; 2000 Oct; 55(10):727-32. PubMed ID: 11082831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recognition of specific sequences in DNA by a topoisomerase I inhibitor derived from the antitumor drug rebeccamycin.
    Bailly C; Colson P; Houssier C; Rodrigues-Pereira E; Prudhomme M; Waring MJ
    Mol Pharmacol; 1998 Jan; 53(1):77-87. PubMed ID: 9443934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel derivatives of pyridylbenzo[b]thiophene-2-carboxamides and benzo[b]thieno[2,3-c]naphthyridin-2-ones: minor structural variations provoke major differences of antitumor action mechanisms.
    Ester K; Hranjec M; Piantanida I; Caleta I; Jarak I; Pavelić K; Kralj M; Karminski-Zamola G
    J Med Chem; 2009 Apr; 52(8):2482-92. PubMed ID: 19331416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.